Bidirectional immunoregulation of calcineurin inhibitor tacrolimus on FOXP3 transcription?

Medical Hypotheses

Volumn 76, Issue 2, 2011, Pages 178-180

  Shen, Zhu ^a   Song, Qiuhe ^a   Chen, Ling ^b   Zhong, Baiyu ^a   Tang, Shuqian ^b   Hao, Fei ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; SMAD3 PROTEIN; STAT6 PROTEIN; TACROLIMUS; TRANSCRIPTION FACTOR FOXP3; TRANSCRIPTION FACTOR GATA 3; TRANSCRIPTION FACTOR NFAT; TRANSCRIPTION FACTOR NFAT1; TRANSCRIPTION FACTOR NFAT2; TRANSCRIPTION FACTOR NFAT3; TRANSCRIPTION FACTOR NFAT4; UNCLASSIFIED DRUG;

ARTICLE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOREGULATION; PROTEIN BINDING; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE;

ANIMALS; CALCINEURIN; CELL NUCLEUS; DOSE-RESPONSE RELATIONSHIP, DRUG; FORKHEAD TRANSCRIPTION FACTORS; GATA3 TRANSCRIPTION FACTOR; GENE EXPRESSION REGULATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; NFATC TRANSCRIPTION FACTORS; PSORIASIS; STAT6 TRANSCRIPTION FACTOR; T-LYMPHOCYTES, REGULATORY; TACROLIMUS; TRANSCRIPTION FACTORS;

EID: 78651226276     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2010.09.011     Document Type: Article

References (29)

1. Valdimarsson H., Thorleifsdottir R.H., Sigurdardottir S.L., Gudjonsson J.E., Johnston A. Psoriasis - as an autoimmune disease caused by molecular mimicry. Trends Immunol 2009, 30:494-501.
2. Jin Y., Mailloux C.M., Gowan K., Riccardi S.L., LaBerge G., Bennett D.C., et al. NALP1 in vitiligo-associated multiple autoimmune disease. N Engl J Med 2007, 356:1216-1225.
3. Griffiths C.E., Barker J.N. Pathogenesis and clinical features of psoriasis. Lancet 2007, 370:263-271.
4. Sakaguchi S., Ono M., Setoguchi R., Yagi H., Hori S., Fehervari Z., et al. Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunol Rev 2006, 212:8-27.
5. Chen L., Shen Z., Wang G., Fan P., Liu Y. Dynamic frequency of CD4+CD25+Foxp3+ Treg cells in psoriasis vulgaris. J Dermatol Sci 2008, 51:200-203.
6. Sugiyama H., Gyulai R., Toichi E., Garaczi E., Shimada S., et al. Dysfunctional blood and target tissue CD4+CD25 high regulatory T cells in psoriasis: mechanism underlying unrestrained pathogenic effector T cell proliferation. J Immunol 2005, 174:164-173.
7. Reynolds N.J., Al-Daraji W.I. Calcineurin inhibitors and sirolimus: mechanisms of action and applications in dermatology. Clin Exp Dermatol 2002, 27:555-561.
8. Shen Z., Chen L., Hao F., Wu J. Transcriptional regulation of Foxp3 gene: multiple signal pathways on the road. Med Res Rev 2009, 29:742-766.
9. Williams L.M., Rudensky A.Y. Maintenance of the Foxp3-dependent developmental program in mature regulatory T cells requires continued expression of Foxp3. Nat Immunol 2007, 8:277-284.
10. Rao A., Luo C., Hogan P.G. Transcription factors of the NFAT family: regulation and function. Ann Rev Immunol 1997, 15:707-747.
11. Al-Daraji W.I., Malak T.T., Prescott R.J., Abdellaoui A., Ali M.M., Dabash T., et al. Expression, localisation and functional activation of NFAT-2 in normal human skin, psoriasis, and cultured keratocytes. Int J Clin Exp Med 2009, 2:176-192.
12. Clipstone N.A., Crabtree G.R. Identification of calcineurin as a key signalling enzyme in T-lymphocyte activation. Nature 1992, 357:695-697.
13. Mantel P.Y., Ouaked N., Rückert B., Karagiannidis C., Welz R., Blaser K., et al. Molecular mechanisms underlying FOXP3 induction in human T cells. J Immunol 2006, 176:3593-3602.
14. Mantel P.Y., Kuipers H., Boyman O., Rhyner C., Ouaked N., Rückert B., et al. PLoS Biol 2007, 5:e329.
15. Massagué J., Blain S.W., Lo R.S. TGFbeta signaling in growth control, cancer, and heritable disorders. Cell 2000, 103:295-309.
16. Yamagiwa S., Gray J.D., Hashimoto S., Horwitz D.A. A role for TGF-beta in the generation and expansion of CD4+CD25+ regulatory T cells from human peripheral blood. J Immunol 2001, 166:7282-7289.
17. Marie J.C., Letterio J.J., Gavin M., Rudensky A.Y. TGF-beta1 maintains suppressor function and Foxp3 expression in CD4+CD25+ regulatory T cells. J Exp Med 2005, 201:1061-1067.
18. Kretschmer K., Apostolou I., Hawiger D., Khazaie K., Nussenzweig M.C., von Boehmer H. Inducing and expanding regulatory T cell populations by foreign antigen. Nat Immunol 2005, 6:1219-1227.
19. Amarnath S., Dong L., Li J., Wu Y., Chen W. Endogenous TGF-beta activation by reactive oxygen species is key to Foxp3 induction in TCR-stimulated and HIV-1-infected human CD4+CD25- T cells. Retrovirology 2007, 4:57.
20. Tone Y., Furuuchi K., Kojima Y., Tykocinski M.L., Greene M.I., Tone M. Smad3 and NFAT cooperate to induce Foxp3 expression through its enhancer. Nat Immunol 2008, 9:194-202.
21. Romano S., Mallardo M., Chiurazzi F., Bisogni R., D'Angelillo A., Liuzzi R., et al. The effect of FK506 on transforming growth factor beta signaling and apoptosis in chronic lymphocytic leukemia B cells. Haematologica 2008, 93:1039-1048.
22. Akool el-S., Doller A., Babelova A., Tsalastra W., Moreth K., Schaefer L., et al. Molecular mechanisms of TGF beta receptor-triggered signaling cascades rapidly induced by the calcineurin inhibitors cyclosporin A and FK506. J Immunol 2008, 181:2831-2845.
23. Kogina K., Shoda H., Yamaguchi Y., Tsuno N.H., Takahashi K., Fujio K., et al. Tacrolimus differentially regulates the proliferation of conventional and regulatory CD4(+) T cells. Mol Cells 2009, 28:125-130.
24. Wang Z., Shi B., Jin H., Xiao L., Chen Y., Qian Y. Low-dose of tacrolimus favors the induction of functional CD4(+)CD25(+)FoxP3(+) regulatory T cells in solid-organ transplantation. Int Immunopharmacol 2009, 9:564-569.
25. Arias-Diaz J., Ildefonso J.A., Mu?oz J.J., Zapata A., Jiménez E. Both tacrolimus and sirolimus decrease Th1/Th2 ratio, and increase regulatory T lymphocytes in the liver after ischemia/reperfusion. Lab Invest 2009, 89:433-445.
26. Xu G., Wang L., Chen W., Xue F., Bai X., Liang L., et al. Rapamycin and tacrolimus differentially modulate acute graft-versus-host disease in rats after liver transplantation. Liver Transpl 2010, 16:357-363.
27. Calvo-Turrubiartes M., Romano-Moreno S., García-Hernández M., Chevaile-Ramos J.A., Layseca-Espinosa E., González-Amaro R., et al. Quantitative analysis of regulatory T cells in kidney graft recipients: a relationship with calcineurin inhibitor level. Transpl Immunol 2009, 21:43-49.
28. Zhou L., Lopes J.E., Chong M.M., Ivanov I.I., Min R., Victora G.D., et al. TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function. Nature 2008, 453:236-240.
29. Ou-Yang H.F., Zhang H.W., Wu C.G., Zhang P., Zhang J., Li J.C., et al. Notch signaling regulates the FOXP3 promoter through RBP-J- and Hes1-dependent mechanisms. Mol Cell Biochem 2009, 320:109-114.